MedTrace Logo

A Comparison of Two Initial Dosing Formulas

NCT01377155 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2013-08-27

No results posted yet for this study

Summary

This study will evaluate two methods of starting basal insulin to see which method may achieve a faster-to-goal titration.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

DRUG

Insulin detemir

Subjects will be randomized to weight based method of 0.1 U/kg for basal insulin or a starting dose based upon an insulin challenge. Subject will record morning fasting blood sugar daily. Using a three day average, the subject will titrate the dose of basal insulin either increasing or lowering by three units based upon target blood glucose of 110 mg/dl.

Sponsors & Collaborators

  • Diabetes Care Center

    lead INDUSTRY

Principal Investigators

  • Allen B King, MD · Diabetes Care Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01377155 on ClinicalTrials.gov